Pustular psoriasis – Diagnostics

Go back

Pustular psoriasis diagnostics involves careful evaluation of skin symptoms, location of pustules, and sometimes additional testing to confirm the diagnosis and rule out other conditions. A healthcare provider will consider multiple factors including the appearance of the skin, medical history, and in some cases, laboratory or biopsy results to properly identify this rare form of psoriasis.

Introduction: Who Should Seek Diagnostic Evaluation

Anyone experiencing sudden appearance of white or yellow pus-filled bumps on their skin, especially if surrounded by red or discolored patches, should consider seeking medical evaluation for pustular psoriasis. This is particularly important if you already have a history of plaque psoriasis or other forms of psoriasis, as people with existing psoriasis can develop pustular variants at any point in their lives.[1]

Immediate medical attention becomes crucial when pustules appear suddenly across large areas of the body, especially if accompanied by fever, chills, severe itching, rapid heart rate, muscle weakness, or extreme fatigue. These symptoms may indicate generalized pustular psoriasis (also called GPP), which is a rare but serious form that can spread quickly and affect your entire body. GPP represents a medical emergency that requires urgent evaluation and treatment.[2][8]

Even when symptoms appear more limited in scope, such as pustules affecting only the palms of your hands, soles of your feet, or tips of your fingers and toes, diagnostic evaluation is advisable. These localized forms of pustular psoriasis can significantly impact daily activities and quality of life, making proper diagnosis important for effective management.[1]

Adults between the ages of 40 and 50 are most commonly affected by pustular psoriasis, though it can occur at any age. While it is more common in adults than children, pustular psoriasis can affect anyone diagnosed with psoriasis. Certain ethnic groups may experience higher rates of pustular psoriasis, making awareness of symptoms particularly important across diverse populations.[1][2]

⚠️ Important
If you notice widespread pustules developing rapidly along with fever, difficulty breathing, rapid pulse, or severe fatigue, seek emergency medical care immediately. Generalized pustular psoriasis can be life-threatening and requires urgent professional evaluation and treatment.

Classic Diagnostic Methods

The diagnosis of pustular psoriasis begins with a thorough physical examination by a healthcare provider, typically a dermatologist. During this examination, your doctor will carefully assess the appearance, distribution, and characteristics of the pustules and any accompanying skin changes. The location where pustules appear provides important diagnostic clues, as pustular psoriasis tends to favor certain body areas depending on the specific type.[1][4]

Your healthcare provider will look for distinctive features that characterize pustular psoriasis. These include small, white or yellowish bumps filled with a sterile fluid that looks like pus, sitting on top of or surrounded by red, inflamed, or discolored patches of skin. The skin patches themselves are typically thick, scaly, and flaky. Unlike infections, the pus in these pustules does not contain bacteria and is not contagious—it results from inflammation within the skin caused by an overactive immune system.[1][2]

The medical history you provide plays a critical role in diagnosis. Your doctor will ask detailed questions about when symptoms first appeared, how quickly they developed, and whether you have experienced similar episodes before. Information about any existing diagnosis of psoriasis or psoriatic arthritis is particularly relevant, since people with plaque psoriasis can develop pustular forms. Your provider will also inquire about potential triggers such as recent medication changes (especially starting or stopping certain drugs like systemic steroids), infections, pregnancy, stress, or exposure to ultraviolet light.[1][6]

In some cases, your healthcare provider may perform a skin biopsy to confirm the diagnosis and rule out other conditions. During a biopsy, a small sample of affected skin is removed and examined under a microscope in a laboratory. The microscopic examination reveals characteristic features of pustular psoriasis, including specific changes in the structure of the skin layers and the presence of certain types of inflammatory cells, particularly neutrophils, which are white blood cells that accumulate in the epidermis (the outer layer of skin).[3][5]

The biopsy typically shows pustules known as “spongiform pustules of Kogoj,” which are collections of neutrophils between skin cells. The overall architecture of the epidermis in pustular psoriasis is similar to that seen in regular plaque psoriasis, with thickening of certain skin layers, elongation of structures called rete ridges, and other distinctive changes. These microscopic findings help dermatologists distinguish pustular psoriasis from other conditions that might cause similar-looking pustules on the skin.[5]

Your doctor will work to differentiate pustular psoriasis from other skin conditions that can produce pustules or blisters. Several conditions can appear similar, including pustular dermatosis, which causes pus-filled blisters under the top skin layer but without the characteristic scaly plaques of psoriasis. Bacterial or fungal skin infections might also produce pustules, but these can usually be identified through bacterial or fungal cultures of the fluid. In some cases, cultures may be performed to confirm that pustules are sterile (free from bacteria), which supports a diagnosis of pustular psoriasis rather than infection.[2][5]

Blood tests may be ordered as part of the diagnostic workup, particularly when generalized pustular psoriasis is suspected. These tests help assess the overall impact of the condition on your body and can reveal signs of systemic inflammation. Common findings include elevated white blood cell counts (particularly neutrophils), increased levels of inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), and changes in blood chemistry that might indicate effects on organs like the liver or kidneys.[5]

In severe cases of generalized pustular psoriasis, blood tests might show decreased levels of albumin (a protein), calcium, and zinc, along with increased levels of other proteins called globulins. If the condition has led to dehydration, tests may show elevated blood urea nitrogen (BUN) and creatinine. Liver enzymes may be elevated if the liver has been affected. Urinalysis might detect protein or other abnormalities if the kidneys are involved in the inflammatory process.[5]

Diagnostics for Clinical Trial Qualification

When patients with pustular psoriasis are being considered for participation in clinical trials, more standardized and specific diagnostic criteria are typically required. Clinical trials investigating new treatments for pustular psoriasis need to ensure that participants have been accurately diagnosed using consistent methods across all study sites and participants. This helps researchers determine whether new therapies are truly effective.[12]

For clinical trial enrollment, confirmation of pustular psoriasis diagnosis typically requires documentation of characteristic clinical features by a dermatologist with expertise in psoriasis. This often includes detailed photographic documentation of affected skin areas, precise measurement of the extent of skin involvement, and sometimes histological confirmation through skin biopsy showing the characteristic features of pustular psoriasis under microscopic examination.[5]

Many clinical trials use standardized scoring systems to measure disease severity and monitor response to treatment. For generalized pustular psoriasis trials, the Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) is commonly used. This scoring system evaluates both the degree of pustulation (how many pustules are present and their characteristics) and the overall severity of skin involvement. A specific GPPGA pustulation subscore measures just the pustule component, while a total score incorporates other features like redness and scaling.[12]

Laboratory testing requirements for clinical trial participation are often more extensive than what is needed for routine diagnosis. Baseline blood tests typically include complete blood counts with detailed analysis of white blood cell types, comprehensive metabolic panels to assess organ function, inflammatory markers like CRP and ESR, and sometimes tests for specific antibodies or immune markers. These baseline values help researchers understand the participant’s starting point and track changes during the trial.[5]

Some clinical trials may include genetic testing as part of their qualification criteria or research objectives. Scientists have identified several genetic mutations associated with pustular psoriasis, particularly in genes involved in immune system regulation such as the IL36RN gene (interleukin 36 receptor antagonist). Mutations in this gene and others like CARD14, AP1S3, MPO, and SERPINA3 have been linked to increased risk of developing pustular psoriasis. While genetic testing is not yet standard for clinical diagnosis, it may be incorporated into research studies to better understand disease mechanisms and identify patients who might respond particularly well to specific treatments.[6]

For trials focusing on localized pustular psoriasis forms, such as palmoplantar pustular psoriasis (affecting hands and feet) or acrodermatitis continua of Hallopeau (affecting finger and toe tips), specific criteria define the required location and extent of involvement. Photographic documentation of these areas before treatment begins is standard, along with detailed measurements of affected surface area and pustule counts.[1]

Exclusion criteria for clinical trials help ensure patient safety and study validity. Patients may be excluded if they have active infections, certain other serious medical conditions, or have recently used medications that might interfere with study results. Documentation that pustules are sterile (not caused by bacterial or fungal infection) may be required through negative bacterial and fungal cultures of pustule fluid.[5]

Imaging studies are not typically required for pustular psoriasis diagnosis or clinical trial qualification, as the condition primarily affects the skin in ways that are visible on physical examination. However, in cases of generalized pustular psoriasis with suspected involvement of internal organs, additional tests such as chest X-rays or other imaging might be performed to assess for complications like respiratory involvement.[5]

Prognosis and Survival Rate

Prognosis

Pustular psoriasis is a lifelong chronic condition, meaning symptoms may come and go throughout a person’s lifetime. The long-term outlook depends largely on the type of pustular psoriasis a person has, how quickly they receive appropriate treatment, and how well they manage potential triggers. For localized forms affecting hands, feet, or digits, the prognosis is generally good with proper treatment, though symptoms can significantly impact daily activities and quality of life when flares occur.[1][2]

Generalized pustular psoriasis represents a more serious form with a more guarded prognosis if left untreated. However, with modern treatments, many patients can achieve good control of symptoms. The condition can be associated with serious complications including systemic inflammation affecting multiple organs such as the liver, kidneys, heart, and lungs. Patients with pustular psoriasis also face increased risk of developing associated conditions including psoriatic arthritis (affecting approximately one in three people with psoriasis), heart disease, diabetes, obesity, and depression.[1][6]

The development of new targeted therapies, including biologic medications and treatments specifically designed for pustular psoriasis, has significantly improved the outlook for many patients. Early diagnosis and initiation of appropriate treatment can help prevent complications and improve long-term outcomes. With advances in understanding the genetic and immune mechanisms underlying pustular psoriasis, future treatments are expected to become even more effective.[1][12]

Survival rate

While specific survival statistics for pustular psoriasis as a whole are not widely reported in the available literature, the condition is generally not directly life-threatening when properly managed. However, acute flares of generalized pustular psoriasis can be serious medical emergencies. Without prompt treatment, severe cases of GPP can lead to life-threatening complications including severe dehydration, infection (due to loss of the skin’s protective barrier), heart failure, kidney failure, or respiratory failure.[6][8]

Impetigo herpetiformis, which is pustular psoriasis occurring during pregnancy, requires special mention as it is associated with increased maternal and fetal morbidity. This form necessitates careful monitoring and management to protect both mother and baby.[6]

With current medical care, including access to emergency treatment for acute flares and effective long-term management strategies, the vast majority of people with pustular psoriasis can expect a normal lifespan. The key factors affecting outcomes include early recognition of serious flares, prompt medical intervention, consistent treatment adherence, and effective management of associated health conditions like cardiovascular disease.[1]

Ongoing Clinical Trials on Pustular psoriasis

  • Study on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Spain

References

https://www.psoriasis.org/pustular/

https://my.clevelandclinic.org/health/diseases/24805-pustular-psoriasis

https://www.ncbi.nlm.nih.gov/books/NBK537002/

https://www.webmd.com/skin-problems-and-treatments/psoriasis/pustular-psoriasis

https://emedicine.medscape.com/article/1108220-overview

https://dermnetnz.org/topics/generalised-pustular-psoriasis

https://www.gainesvilledermatologyskinsurgery.com/pustular-psoriasis/

https://pmc.ncbi.nlm.nih.gov/articles/PMC12279558/

https://www.aad.org/public/diseases/psoriasis/treatment/medications/pustular

https://www.psoriasis.org/pustular/

https://pmc.ncbi.nlm.nih.gov/articles/PMC5683122/

https://emedicine.medscape.com/article/1108220-treatment

FAQ

How can doctors tell the difference between pustular psoriasis and a skin infection?

Doctors distinguish pustular psoriasis from infection by examining the appearance and pattern of pustules, reviewing your medical history, and sometimes performing bacterial or fungal cultures of the pustule fluid. In pustular psoriasis, cultures come back negative (sterile) because the pus is caused by inflammatory cells, not bacteria. Additionally, pustular psoriasis typically shows characteristic patterns and locations, often accompanied by the thick, scaly skin plaques typical of psoriasis, which infections do not produce.[2][5]

Do I need a skin biopsy to diagnose pustular psoriasis?

A skin biopsy is not always necessary for diagnosing pustular psoriasis. Many cases can be diagnosed based on the characteristic appearance of pustules and skin patches, their location, and your medical history. However, your doctor may recommend a biopsy if the diagnosis is uncertain or if they need to rule out other conditions that look similar. The biopsy helps confirm the diagnosis by revealing specific microscopic features unique to pustular psoriasis.[3][5]

What blood tests are used to diagnose pustular psoriasis?

Blood tests cannot directly diagnose pustular psoriasis, but they help assess the severity of inflammation and the impact on your body. Common tests include complete blood count (showing elevated white blood cells), inflammatory markers like C-reactive protein and erythrocyte sedimentation rate, and metabolic panels to check organ function. These tests are particularly important in generalized pustular psoriasis to evaluate systemic involvement and guide treatment decisions.[5]

Should I see a dermatologist or can my regular doctor diagnose pustular psoriasis?

While your regular doctor can recognize concerning symptoms and provide initial evaluation, pustular psoriasis should be diagnosed and managed by a dermatologist whenever possible. Dermatologists have specialized training in distinguishing pustular psoriasis from other skin conditions and are most qualified to determine the specific type and develop an appropriate treatment plan. For acute generalized pustular psoriasis with severe symptoms, emergency medical care is needed first, followed by dermatology consultation.[1][8]

How long does it take to get a diagnosis of pustular psoriasis?

The time to diagnosis varies depending on your specific situation. If you see a dermatologist with classic symptoms, diagnosis may be made during the first visit based on physical examination and medical history. If a skin biopsy is needed, results typically take several days to a week. In emergency situations with generalized pustular psoriasis, immediate clinical diagnosis allows treatment to begin right away, with confirmatory tests following. Delays can occur if initial doctors are unfamiliar with this rare condition or if symptoms are atypical.[4][5]

🎯 Key takeaways

  • Pustular psoriasis diagnosis primarily relies on physical examination of pustule appearance and location, combined with medical history, rather than requiring complex testing in most cases
  • The pus in pustular psoriasis is sterile and non-contagious, distinguishing it from bacterial infections that may look similar
  • Immediate medical attention is critical for generalized pustular psoriasis with widespread pustules and systemic symptoms like fever, as this can be life-threatening
  • Skin biopsy revealing “spongiform pustules of Kogoj” and neutrophil accumulation confirms diagnosis when physical examination alone is insufficient
  • Blood tests help assess inflammation severity and organ involvement in pustular psoriasis but cannot diagnose the condition by themselves
  • Recent genetic discoveries about IL36RN and other gene mutations are advancing our understanding of pustular psoriasis, though genetic testing is not yet standard clinical practice
  • Clinical trial participation requires more extensive diagnostic documentation, including standardized scoring systems like the GPPGA and detailed photographic records
  • Early and accurate diagnosis enables prompt treatment that can prevent serious complications and significantly improve quality of life for people living with pustular psoriasis

Connected medications: